+ All Categories
Home > Documents > N-nitrosodiethylamine-induced toxicity in relation to oxidative stress and development of...

N-nitrosodiethylamine-induced toxicity in relation to oxidative stress and development of...

Date post: 05-Sep-2016
Category:
Upload: gaurav-mittal
View: 215 times
Download: 4 times
Share this document with a friend
6
Experimental and Toxicologic Pathology 59 (2008) 409–414 N-nitrosodiethylamine-induced toxicity in relation to oxidative stress and development of atherosclerosis in hypercholesterolemic diet-fed rabbits Gaurav Mittal a, , Apminder Pal Singh Brar b , Giridhar Soni a a Department of Biochemistry and Chemistry, Punjab Agricultural University, Ludhiana 141 004, India b Department of Veterinary Pathology, Punjab Agricultural University, Ludhiana 141 004, India Received 3 May 2007; accepted 31 October 2007 Abstract N-nitrosodiethylamine (NDEA) is an important carcinogenic nitrosamine frequently present in human environment, besides being a part of the human food chain by virtue of its reported presence in various foodstuffs and beverages. This study was planned to investigate the toxicity of NDEA in relation to the development of atherosclerosis in experimental rabbits. Oral administration of NDEA at 50 mg per day along with hypercholesterolemic diet to rabbits resulted in significant increase in osmotic fragility of erythrocytes as well as increased in vitro lipid peroxidation (LPO) of erythrocytes. The plasma total lipids, cholesterol and glycerides continued to increase during the feeding of hypercholesterolemic diet with or without NDEA. However, after the cessation of hypercholesterolemic diet, decrease in the lipid fractions was relatively less in the experimental group receiving NDEA. Administration of NDEA in the hypercholesterolemic diet did not affect the total lipid content in the liver, although it marginally increased the hepatic cholesterol levels. Histopathological changes in different tissues (heart, aorta and liver) were relatively more severe in experimental rabbits receiving NDEA treatment as compared to the control ones. Our study therefore indicates that oral administration of NDEA results in increased LPO of blood and decreased lipid clearance, which may in turn result in increased degree of atherosclerosis. r 2007 Elsevier GmbH. All rights reserved. Keywords: N-nitrosodiethylamine (NDEA); Hypercholesterolemia; Oxidative stress; Atherosclerosis; Rabbit Introduction N-nitroso compounds are important chemical carci- nogens that pose a significant human health hazard (Aiub et al., 2003; Knekt et al., 1999). Presence of nitroso compounds like N-nitrosodiethylamine, N-nitrosodimethy- lamine, N-nitrosopyrrolidine and N-nitrosopiperidine has been widely reported in various foodstuffs such as milk products, meat products, soft drinks and alcoholic beverages (Levallois et al., 2000; Prasad and Krishnas- wamy, 1994; Tricker et al., 1991) along with their reported presence in tobacco smoke that accounts for one of the biggest causes for individual exposure to these nitrosamines (Wu et al., 2005). The cellular and molecular changes induced by some nitroso compounds in animals have been shown to be very similar to those in human tissues (Bartsch, 1991; Bansal and Bhatnagar, 1998). The nitroso compounds such as N-nitrosodiethy- lamine (NDEA) have been suggested to cause oxidative ARTICLE IN PRESS www.elsevier.de/etp 0940-2993/$ - see front matter r 2007 Elsevier GmbH. All rights reserved. doi:10.1016/j.etp.2007.10.009 Corresponding author at: Institute of Nuclear Medicine and Allied Sciences, Brig. S.K. Mazumdar Marg, Delhi 110 054, India. Tel.: +91 11 23905125; fax: +91 11 23919509. E-mail address: [email protected] (G. Mittal).
Transcript

ARTICLE IN PRESS

0940-2993/$ - se

doi:10.1016/j.et

�CorrespondSciences, Brig.

Tel.: +9111 23

E-mail addr

Experimental and Toxicologic Pathology 59 (2008) 409–414

www.elsevier.de/etp

N-nitrosodiethylamine-induced toxicity in relation to oxidative stress and

development of atherosclerosis in hypercholesterolemic diet-fed rabbits

Gaurav Mittala,�, Apminder Pal Singh Brarb, Giridhar Sonia

aDepartment of Biochemistry and Chemistry, Punjab Agricultural University, Ludhiana 141 004, IndiabDepartment of Veterinary Pathology, Punjab Agricultural University, Ludhiana 141 004, India

Received 3 May 2007; accepted 31 October 2007

Abstract

N-nitrosodiethylamine (NDEA) is an important carcinogenic nitrosamine frequently present in human environment,besides being a part of the human food chain by virtue of its reported presence in various foodstuffs and beverages.This study was planned to investigate the toxicity of NDEA in relation to the development of atherosclerosis inexperimental rabbits. Oral administration of NDEA at 50mg per day along with hypercholesterolemic diet to rabbitsresulted in significant increase in osmotic fragility of erythrocytes as well as increased in vitro lipid peroxidation (LPO)of erythrocytes. The plasma total lipids, cholesterol and glycerides continued to increase during the feeding ofhypercholesterolemic diet with or without NDEA. However, after the cessation of hypercholesterolemic diet, decreasein the lipid fractions was relatively less in the experimental group receiving NDEA. Administration of NDEA in thehypercholesterolemic diet did not affect the total lipid content in the liver, although it marginally increased the hepaticcholesterol levels. Histopathological changes in different tissues (heart, aorta and liver) were relatively more severe inexperimental rabbits receiving NDEA treatment as compared to the control ones. Our study therefore indicates thatoral administration of NDEA results in increased LPO of blood and decreased lipid clearance, which may in turnresult in increased degree of atherosclerosis.r 2007 Elsevier GmbH. All rights reserved.

Keywords: N-nitrosodiethylamine (NDEA); Hypercholesterolemia; Oxidative stress; Atherosclerosis; Rabbit

Introduction

N-nitroso compounds are important chemical carci-nogens that pose a significant human health hazard(Aiub et al., 2003; Knekt et al., 1999). Presence of nitrosocompounds like N-nitrosodiethylamine, N-nitrosodimethy-lamine, N-nitrosopyrrolidine and N-nitrosopiperidine has

e front matter r 2007 Elsevier GmbH. All rights reserved.

p.2007.10.009

ing author at: Institute of Nuclear Medicine and Allied

S.K. Mazumdar Marg, Delhi 110 054, India.

905125; fax: +91 11 23919509.

ess: [email protected] (G. Mittal).

been widely reported in various foodstuffs such as milkproducts, meat products, soft drinks and alcoholicbeverages (Levallois et al., 2000; Prasad and Krishnas-wamy, 1994; Tricker et al., 1991) along with theirreported presence in tobacco smoke that accounts forone of the biggest causes for individual exposure to thesenitrosamines (Wu et al., 2005). The cellular andmolecular changes induced by some nitroso compoundsin animals have been shown to be very similar to thosein human tissues (Bartsch, 1991; Bansal and Bhatnagar,1998). The nitroso compounds such as N-nitrosodiethy-lamine (NDEA) have been suggested to cause oxidative

ARTICLE IN PRESSG. Mittal et al. / Experimental and Toxicologic Pathology 59 (2008) 409–414410

stress and cellular injury due to the involvement of freeradicals (Bartsch et al., 1989; Masuda et al., 2000).In vitro studies in human and rat erythrocytes have alsoshown that NDEA exposure increases lipid peroxidation(LPO) and decreases the activity of antioxygenicenzymes (Mittal et al., 2006; Bansal et al., 1996).

Atherosclerosis disease remains a leading cause ofdeath in the world, and reactive oxygen species (ROS)play a pivotal role in atherogenesis (Cai and Harrison,2000; Chisolm and Steinberg, 2000). There is now aconsensus that atherosclerosis represents a state ofheightened oxidative stress characterized by lipid andprotein oxidation in the vascular wall (Stocker andKeaney, 2004). Oxidative stress results from excessivegeneration of ROS that outstrips the antioxidant system(Yung et al., 2006). Thus, the present investigation wasaimed at studying the NDEA-induced toxicity andoxidative stress in relation to development of athero-sclerosis in rabbits.

Materials and methods

All the chemicals used in the present study were ofanalytical grade. NDEA was purchased from SigmaChemical Company, St. Louis, MO, USA.

The Social Justice and Empowerment Committee forthe purpose of Control and Supervision of Experimentson Animals, Ministry of Government of India, NewDelhi approved the animal experiments. Disease-freemale rabbits (3–4 months) were obtained from theVeterinary College of Punjab Agricultural University,Ludhiana. The rabbits were divided into two groups of6 rabbits each. All the rabbits were housed individuallyand were given free access to water and normal pelletdiet meant for laboratory animals. In addition, animalswere given cholesterol at 500mg/day orally, mixed with

Table 1. Effect of NDEA on Hb, osmotic fragility and in vitro LP

hypercholesterolemia in rabbits

Feeding

period (days)

Hb (g/dL) Osmotic frag

C E C

Development phase

0 12.8070.19 12.6570.36 32.1471.86

15 12.6670.76 12.7070.45 34.6771.99

30 12.4570.36 12.6170.06 39.0271.52

60 11.9170.13 11.9470.12 46.2071.72

Reversal phase

90 12.5970.28 12.4570.07 45.1273.60

120 12.7070.32 12.5470.03 55.7270.69

150 12.3270.35 12.2170.21 65.9070.33

Values are mean7S.D., n ¼ 6. C ¼ Control group. E ¼ Experimental groupaPo0.01.bPo0.05 with respect to the control group.

50 g of decorted gram soaked overnight, for 2 months toinduce hypercholesterolemia and hence atherosclerosis.Group II rabbits were also given NDEA at 50mg/dayalong with hypercholesterolemic diet. The dose ofNDEA was chosen on the basis of previous studiesinvolving experimental rats reported from our lab(Kaushal et al., 2003). After 2 months, the cholesterolwas withdrawn from the diets of both the groups whileNDEA treatment continued for another 3 months in theNDEA-fed group. Blood samples were drawn at 15, 30,60, 90, 120 and 150 days of the experimental period. Allthe rabbits were sacrificed at the end of the experimentalperiod. Liver, heart and aorta were collected forbiochemical and histopathological analysis. The aortawas cut open longitudinally, fixed for 24–48 h in neutralbuffered formalin and stained in bulk with Sudan IV(Holman et al., 1958). Percentage of total intimalsurface involved by atherosclerotic lesions was calcu-lated and lesions were graded according to therecommendations of the WHO study group on athero-sclerosis (1958). Blood was analyzed for hemoglobin(Hb) and osmotic fragility (Dacie and Lewis, 1968).In vitro LPO of erythrocytes was determined by themethod of Stocks and Dormandy (1971). Plasma andtissue (liver and heart) were analyzed for lipid profile bythe methods previously described from our lab (Vadheraet al., 2003). All data were expressed as mean7standarddeviation, and Student’s t-test was used for comparativeanalysis. The results were considered significant if thep-value was 0.05 or less.

Results

Supplementation of NDEA in hypercholesterolemicdiet did not affect the Hb content of experimentalrabbits as compared to control (Table 1). However,

O in erythrocytes during development and reversal phases of

ility (% hemolysis) LPO (nmol of MDA formed/g/Hb/h)

E C E

34.3372.93 613.3078.79 623.92712.97

39.7271.94b 620.25714.18 647.48718.80a

44.9674.15a 654.00712.93 710.60715.77a

56.4071.28a 753.96718.08 888.32719.38a

63.7272.93a 778.86714.18 957.48728.87a

76.5272.10a 821.98719.81 988.10718.80a

79.6470.42a 854.67720.59 1047.32728.66a

(NDEA treated).

ARTICLE IN PRESS

Table

2.

ToxicityofNDEA

inrelationto

developmentofhypercholesterolemia

inrabbits–effect

onplasm

alipid

profile

(mg/dL)

Feedingperiod

(days)

Totallipids

Cholesterol

Freefattyacids

Phospholipids

Glycerides

CE

CE

CE

CE

CE

Dev

elo

pm

ent

ph

ase

0211.35743.24

205.24745.65

62.3378.51

64.8779.23

16.3273.12

15.8873.24

90.42712.24

87.38715.96

42.2876.72

37.1175.89

15

398.33761.83

410.83769.75

182.68716.77

194.13718.25

30.1076.41

29.9175.53

105.33713.59

102.26714.78

80.22710.16

84.53711.29

30

608.90790.10

616.70786.70

312.50724.43

337.50724.43

65.7076.39

62.2475.22

124.12716.88

121.67714.97

106.58715.96

95.29713.37

60

974.307108.90

999.507117.30

522.50778.66

567.50775.29

107.18716.46

103.16716.36

230.84740.56

232.55741.30

113.78715.96

96.29715.37

Rev

ersa

lp

ha

se

90

722.20795.40

750.60790.30

377.50718.86

437.50727.17a

69.6775.87

65.1376.29b

155.60722.80

142.58720.24

119.43716.81

105.39713.27

120

655.55795.60

705.95789.90

302.50714.84

367.50717.52a

71.2576.37

64.1476.56

150.40720.12

146.86717.28

131.40724.35

127.45725.33

150

607.30794.30

641.50790.50

287.50715.98

335.00714.04a

68.8776.35

67.9277.14

132.34718.96

128.52720.26

118.59716.81

110.06712.18

Values

are

mean7S.D

.,n¼

6.C¼

Controlgroup.E¼

Experim

entalgroup(N

DEA

treated).

aPo0.01.

bPo0.05withrespectto

controlgroup.

G. Mittal et al. / Experimental and Toxicologic Pathology 59 (2008) 409–414 411

NDEA administration resulted in a substantial andsignificant increase in osmotic fragility of erythrocytesand the effect was more pronounced with increasingfeeding period and continued to increase even afterwithdrawal of hypercholesterolemic diet. Moreover,withdrawal of hypercholesterolemic diet did not im-prove the antioxygenic potential of erythrocytes; ratherthe antioxygenic potential continued to decrease asevidenced by increased in vitro LPO of erythrocytes inNDEA-fed groups. Feeding of cholesterol diet resultedin a substantial increase in total plasma lipids, choles-terol and glycerides, which continued to increase withthe feeding period (Table 2). No significant effect onlevels of plasma total lipids, cholesterol, free fatty acids,phospholipids and glycerides was seen on NDEAadministration. After the cession of cholesterol feeding,the levels of lipid fractions continued to decrease withthe progression of the feeding period; however, thedecrease was relatively slower in the experimental groupreceiving NDEA. The effect of NDEA was significantonly on cholesterol levels. The effect on other lipidfractions was only a marginal one. Relatively higherlevels of lipids and cholesterol in plasma in NDEA-administered rabbits indicate that NDEA interferes withthe clearance of lipids and cholesterol from the body,thus making the animals at a higher risk of developingatherosclerosis. Administration of NDEA did not affectthe total lipid content of the liver; however, there wassignificant increase in cholesterol level and cholesterol tophospholipid ratio (Table 3), indicating that NDEApromotes deposition of cholesterol in the biomem-branes. There was a decrease in the level of free fattyacids in the NDEA-fed group as compared to thecontrol. However, the glyceride fraction remained moreor less unaffected in the two groups. The total lipid andglyceride content of the heart in the NDEA-fed groupdecreased significantly as compared to control but thecholesterol and free fatty acids were more or lessunaffected in the two groups. However, the phospholi-pid content decreased, resulting in significant increase incholesterol: phospholipids ratio.

The toxicity of NDEA under hypercholesterolemicdietary conditions on the histopathology of varioustissues (heart, aorta and liver) of rabbits was studied andis summarized in Table 4. Feeding of hypercholester-olemic diet resulted in accumulation of fat droplets inmyocardium cells. Mild to moderate fatty changes wereseen in the myocardium along with the coronary artery.However, administration of NDEA along with hyperch-olesterolemic diet resulted in increased severity ofchanges and there was also accumulation of lipids inthe localized area of coronary blood vessels (Fig. 1). Inthe aorta, there was accumulation of fat droplets intunica media, which caused its thickening and there wasa decrease in size of the lumen when only hypercholes-terolemic conditions prevailed. However, the effects

ARTICLE IN PRESS

Table 3. Effect of NDEA on hepatic and cardiac lipid profile (mg/g tissue)

Parameter Liver Heart

C E C E

Total lipids 76.2571.87 77.5071.73 Total lipids 57.5073.88 46.2573.44a

Cholesterol 24.1370.68 28.0070.57a Cholesterol 8.2571.25 7.6371.72

FFA 9.8070.20 6.2070.19a FFA 3.8070.99 3.4070.89

Phospholipids 14.1470.41 14.8070.41b Phospholipids 17.1170.75 11.7870.98a

Glycerides 28.2870.79 28.5070.65 Glycerides 28.3471.12 23.4471.16a

Values are mean7S.D., n ¼ 6. C ¼ Control group. E ¼ Experimental group (NDEA treated).aPo0.01.bPo0.05 with respect to the control group.

Table 4. Oral toxicity of NDEA in relation to hypercholes-

terolemia in rabbits – effect on histopathology of various

tissues

Tissue/pathological changes Treatment/effect

C E

Heart

Accumulation of cholesterol in tunica

intima of coronary blood vessel

++ +++

Accumulation of lipids in

myocardium

++ +++

Aorta

Accumulation of lipids ++ +++

Liver

Accumulation of fat/lipid in

hepatocytes

+++ +++

Infiltration of mononuclear cells + +++

Fibrosis – +++

Regeneration of hepatocytes + ++

C ¼ Control group. E ¼ Experimental group (NDEA treated).

� Normal.

+Mild.

++Moderate.

+++Severe.

Fig. 1. Section of heart showing accumulation of lipids in the

localized area of coronary blood vessel (arrow) in the presence

of NDEA (H.E.� 20 magnification).

Fig. 2. Section of aorta showing increased thickness of tunica

media (arrow) due to accumulation of fat droplets in the

presence of NDEA (H.E.� 40 magnification).

G. Mittal et al. / Experimental and Toxicologic Pathology 59 (2008) 409–414412

were more severe in the presence of NDEA (Fig. 2).Surface area of aorta involved in atherosclerosis(sudanophilic lesions) was relatively higher in NDEA-fed groups (25.4071.81%, n ¼ 5) as compared to thatof the control (15.2071.48%, n ¼ 5), indicating thatNDEA induces increased development of atherosclero-sis. In case of liver, there were severe granular changes inthe hepatocytes along with infiltration of mononuclearcells and accumulation of lipids (Figs. 3 and 4).Cholesterol overload is already known to induce liverfibrosis in rabbits (Buyssens et al., 1996). The effectswere, however, more profound in animals of experi-mental group receiving NDEA in their diet (Fig. 5).Fibrosis and other hepatic degenerative changes can be

attributed to the increased LPO of hepatocytes uponNDEA administration, indicating peroxidative damageleading to histopathological degenerative changes.

ARTICLE IN PRESS

Fig. 3. Section of liver showing granular changes in hepato-

cytes (lower arrow) and lymphocyte aggregation (upper arrow)

in the absence of NDEA (H.E.� 40 magnification) (middle

arrow is an artifact).

Fig. 4. Section of liver showing proliferation of connective

tissue indicating fibrosis (arrows) in the absence of NDEA

(H.E.� 40 magnification).

Fig. 5. Section of liver showing accumulation of large-sized fat

droplets (arrows) and fibrosis in the presence of NDEA

(H.E.� 40 magnification).

G. Mittal et al. / Experimental and Toxicologic Pathology 59 (2008) 409–414 413

Discussion

Nitroso compounds such as NDEA have beensuggested to cause oxidative stress and cellular injurydue to the involvement of free radicals (Bartsch et al.,1989). Exposure to NDEA and other nitrosamines hasbeen shown to increase LPO and alter the antioxidantstatus of experimental animals (Mittal et al., 2006,2007). It is well established now that ROS play a pivotalrole in the development and progression of athero-sclerosis, a disease which is the major source ofmorbidity and mortality in the world, and is character-ized by the accumulation of cholesterol deposits in large-and medium-sized arteries (Stocker and Keaney, 2004;Ross, 1993). Keeping this in mind, it was thought thatexposure to nitrosamines such as NDEA through food,beverage or smoking, as already mentioned earlier, maycontribute to an increased risk of developing athero-sclerosis in a vast majority of population that consumesa high-fat diet.

In the present study, oral administration of NDEAhas been shown to result in increased LPO of blood anddecreased lipid clearance in experimental rabbits. Theincreased osmotic fragility in experimental rabbits canbe due to the increased LPO of erythrocytes. Moreover,withdrawal of hypercholesterolemic diet did not im-prove the antioxygenic potential of erythrocytes; ratherthe antioxygenic potential continued to decrease asevidenced by increased in vitro LPO of erythrocytes inNDEA-fed groups. This could be due to the continuedprevalence of hypercholesterolemia/hyperlipidemia ob-served. NDEA administration has already been shownto increase in vitro LPO of erythrocytes in normal aswell as hypercholesterolemic rats (Kaushal et al., 2003;Mittal et al., 2006).

Relatively higher levels of lipids and cholesterol inplasma in NDEA-administered rabbits indicate thatNDEA interferes with the clearance of lipids andcholesterol from the body, thus making the animals ata higher risk of developing atherosclerosis. Moreover, asignificant increase in cholesterol: phospholipids ratio inthe heart and liver tissues of NDEA-fed rabbits indicatethat NDEA promotes deposition of cholesterol in thebiomembranes. The decreased lipid clearance observedon NDEA administration can be due to the alteredfunctions of liver and extra-hepatic tissues resultingfrom the oxidative stress caused by NDEA, as it hasbeen shown to increase LPO of hepatic and other tissuesby interfering with their antioxidant system (Mittalet al., 2006; Bansal et al., 2000).

The effect of NDEA on the histopathology of hearttissue of hypercholesterolemic rabbits showed anincreased accumulation of fat droplets in myocardiumcells and accumulation of lipid in the localized area ofcoronary blood vessels as compared to control. Thisagrees well with the observed increase in cholesterolto phospholipid ratio in heart. The relatively highersurface area of the aorta involved in atherosclerosis

ARTICLE IN PRESSG. Mittal et al. / Experimental and Toxicologic Pathology 59 (2008) 409–414414

(sudanophilic lesions) in NDEA-fed groups (nearly 25%)as compared to that of the control (nearly 15%) indicatesthat NDEA induces increased development of athero-sclerosis. Hypercholesterolemia is obviously known toincrease atherosclerotic changes in the aorta (Das et al.,2006; Mahfouz et al., 1997). Early events of atherogenesishave been reported to be mediated by generation of ROSand oxidation of lipids and proteins in the vascular wall(Stocker and Keaney, 2004; Cai and Harrison, 2000). AsNDEA has been shown to cause oxidative stress andcellular injury due to involvement of free radicals (Bansalet al., 1996; Kaushal et al., 2003), the higher degree ofatherosclerotic plaque observed is obvious.

Thus it appears that oral administration of NDEAresults in increased LPO of blood and decreased lipidclearance, which in turn may result in an increaseddegree of atherosclerosis. The underlying molecularmechanisms, however, need to be further investigated.

Acknowledgment

The authors are grateful to the Head, Department ofBiochemistry and Chemistry for providing necessaryfacilities for the study, and to Mr. Avtar Singh fortechnical help.

References

Aiub CA, Pinto LF, Felzenszwalb I. N-Nitrosodiethylamine

mutagenicity at low concentrations. Toxicol Lett 2003;145:

36–45.

Bansal AK, Bhatnagar D. In vitro effect of N-nitrosodiethy-

lamine on lipid peroxidation and antioxidant enzymes in rat

erythrocytes. Fresenius Environ Bull 1998;7:264–8.

Bansal AK, Bhatnagar D, Soni GL. In vitro effect of

N-nitrosodiethylamine on lipid peroxidation and antiox-

idant system in human erythrocytes. Toxicol In Vitro

1996;10:649–53.

Bansal AK, Trivedi R, Soni GL, Bhatnagar D. Hepatic and

renal oxidative stress in acute toxicity of N-nitrosodiethy-

lamine in rats. Indian J Exp Biol 2000;38:916–20.

Bartsch H. N-nitroso compounds and human cancer, where do

we stand? IARC Sci Publ 1991;105:1–10.

Bartsch H, Hietanen E, Malaveille C. Carcinogenic nitrosa-

mines: free radical aspects of their action. Free Rad Biol

Med 1989;7:637–44.

Buyssens N, Kockx MM, Herman AG, Lazou JM, Van den

Berg K, Wisse E, et al. Centrolobular liver fibrosis in the

hypercholesterolemic rabbit. Hepatology 1996;24:939–46.

Cai H, Harrison DG. Endothelial dysfunction in cardiovas-

cular diseases: the role of oxidant stress. Circ Res 2000;87:

840–4.

Chisolm GM, Steinberg D. The oxidative modification

hypothesis of atherogenesis: an overview. Free Radic Biol

Med 2000;28:1815–26.

Dacie JV, Lewis SM. Practical haematology, 4th ed. London:

Churchill; 1968. p. 95.

Das S, Ray R, Snehlata Das N, Srivastava LM. Effect of

ascorbic acid on prevention of hypercholesterolemia

induced atherosclerosis. Mol Cell Biochem 2006;285:

143–7.

Holman RL, McGill HC, Strong JR, Geer JC. The natural

history of atherosclerosis, the early aortic lesions as seen in

New Orleans in the middle of 20th century. Am J Pathol

1958;34:209–35.

Kaushal V, Sharma S, Brar APS, Soni G. Impact of

antioxidants on N-nitrosodiethylamine-induced biochem-

ical toxicity in rats. Toxicol Int 2003;10:81–7.

Knekt P, Jarvinen R, Dich J, Hakulinen T. Risk of colorectal

and other gastro-intestinal cancers after exposure to nitrate,

nitrite and N-nitroso compounds: a follow-up study. Int J

Cancer 1999;80:852–6.

Levallois P, Ayotte P, van Maanen JM, Desrosiers T, Gingras

S, Dallinga JW, et al. Excretion of volatile nitrosamines in a

rural population in relation to food and drinking water

consumption. Food Chem Toxicol 2000;38:1013–9.

Mahfouz MM, Karwano H, Kummerow FA. Effect of

cholesterol rich diets with and without added vit. E and C

on severity of atherosclerosis in rabbits. Am J Clin Nutr

1997;66:1240–9.

Masuda M, Mower HF, Pignatelli B, Celan I, Friesen MD,

Nishino H, et al. Formation of N-nitrosamines and

N-nitramines by the reaction of secondary amines with

peroxynitrite and other reactive nitrogen species: compar-

ison with nitrotyrosine formation. Chem Res Toxicol 2000;

13:301–8.

Mittal G, Brar APS, Soni G. Impact of hypercholesterolemia

on toxicity of N-nitrosodiethylamine: biochemical and

histopathological effects. Pharmacol Rep 2006;58:413–9.

Mittal G, Vadhera S, Brar APS, Soni G. Protective role of

dietary fibre on N-nitrosopyrrolidine induced toxicity in

hypercholesterolemic rats. Hum Exp Toxicol 2007;26:91–8.

Prasad MPR, Krishnaswamy K. N-nitrosamines in Indian

beers. Indian J Med Res 1994;100:299–301.

Ross R. The pathogenesis of atherosclerosis: a perspective for

the 1990s. Nature 1993;362:801–9.

Stocker R, Keaney Jr JF. Role of oxidative modifications in

atherosclerosis. Physiol Rev 2004;84:1381–478.

Stocks J, Dormandy TL. Autoxidation of human red cell lipids

induced by hydrogen peroxide. Br J Haematol 1971;20:

95–111.

Tricker AR, Pfundstein B, Theobald E, Preussmann R,

Spiegelhalder B. Mean daily intake of volatile N-nitrosamines

from foods and beverages in West Germany in 1989–90.

Food Chem Toxicol 1991;29:729–32.

Vadhera S, Walia S, Soni G. Hyocholesterolemic/hypolipi-

demic effects of fibre from leafy vegetables (Spinach and

Mustard). J Food Sci Technol 2003;40:531–3.

WHO. Classification of atherosclerotic lesions: report of a

study group. WHO Technol Rep Ser 1958:1–20.

Wu W, Zhang L, Jain RB, Ashley DL, Watson CH.

Determination of carcinogenic tobacco-specific nitrosamines

in mainstream smoke from US-brand and non-US-brand

cigarettes from 14 countries. Nicotine Tob Res 2005;7:443–51.

Yung LM, Leung FP, Yao X, Chen ZY, Huang Y. Reactive

oxygen species in vascular wall. Cardiovasc Hematol

Disord Drug Targets 2006;6:1–19.


Recommended